Feed

24/03/2023
Build­ing Safety Act Re­gister opens next month: a step-by-step guide to...
A new Na­tion­al Re­gister of high­er risk build­ings in Eng­land is due to open in April 2023 (the “Re­gister”).  The Re­gister, set up by the new Build­ing Safety Reg­u­lat­or as a con­sequence of the Build­ing...
24/03/2023
CMS UK Tax Dis­putes Di­gest (March 2023)
Wel­come to the March 2023 edi­tion of our UK Tax Dis­putes Di­gest: a high-level sum­mary of key de­vel­op­ments in con­ten­tious tax over the last few months for heads of tax, fin­ance dir­ect­ors, gen­er­al coun­sel...
24/03/2023
CMS ad­vises Brook­field on ac­quis­i­tion of stake in X-ELIO
In­ter­na­tion­al law firm CMS ad­vised Brook­field Re­new­able (Brook­field), one of the world’s largest pub­licly traded, pure-play re­new­able power plat­forms, on its ac­quis­i­tion of a fur­ther 50% stake in glob­al...
23/03/2023
A glob­al move to­wards ban­ning em­ploy­ment con­tract non-com­pete clauses?...
What does the fu­ture hold for busi­nesses look­ing to re­tain law­fully their mar­ket po­s­i­tions and pre­vent un­fair com­pet­i­tion from ex-em­ploy­ees, share­hold­ers and oth­er stake­hold­ers? Re­cent de­vel­op­ments in...
23/03/2023
CMS European M&A Study 2023: Re­cord num­ber of deals last year des­pite chal­len­ging...
The CMS Cor­por­ate/M&A Group is pleased to launch the 15th edi­tion of the European M&A Study­It has been a chal­len­ging year for M&A in view of rising in­fla­tion and in­terest rates, slow­ing growth and in­creased...
23/03/2023
European Pat­ent Of­fice (EPO) dig­ging its heals in over the need for de­scrip­tion...
As a com­ple­ment to the 10th edi­tion of the EPO "Case Law of the Boards of Ap­peal" (CLB), the EPO has pub­lished an An­nu­al Re­view con­tain­ing sum­mar­ies of de­cisions from 2022. The re­view provides a them­at­ic...
27/04/2023
CMS Shef­field Con­struc­tion Fo­cus
We are very pleased to wel­come you to the latest edi­tion of our Con­struc­tion Fo­cus break­fast sem­in­ar series, tak­ing place at our Shef­field of­fices on 27 April 2023. This event is the second in­stal­ment...
22/03/2023
ESG in­vest­ing - key con­sid­er­a­tions
En­vir­on­ment­al, So­cial, and Gov­ernance (“ESG”) in­vest­ing is the con­sid­er­a­tion of ESG factors along­side fin­an­cial factors in the in­vest­ment de­cision-mak­ing pro­cess. By in­teg­rat­ing ESG con­sid­er­a­tions in­to fin­an­cial de­cisions, in­vestors can align in­vest­ments with their val­ues, pro­mote sus­tain­able eco­nom­ic growth, and mit­ig­ate risk.
22/03/2023
European Pat­ent Of­fice (EPO) level of dis­clos­ure re­quired for an­ti­bod­ies...
As a com­ple­ment to the 10th edi­tion of the EPO "Case Law of the Boards of Ap­peal" (CLB), the EPO has pub­lished an An­nu­al Re­view con­tain­ing sum­mar­ies of de­cisions from 2022. The re­view provides a them­at­ic...
22/03/2023
CMS European M&A Study 2023
The CMS Cor­por­ate/M&A Group is pleased to launch the 15th edi­tion of the European M&A Study
22/03/2023
CMS ad­vises Com­cast on new stream­ing part­ner­ship in Africa
In­ter­na­tion­al law firm CMS ad­vised NB­CUni­ver­sal and Sky (both owned by Com­cast) on their new part­ner­ship with Afric­an me­dia com­pany Mul­tiChoice Group for the Show­max stream­ing ser­vice.  CMS ad­vised on...
21/03/2023
Is a pa­tient in a clin­ic­al tri­al con­sidered to be a mem­ber of the pub­lic...
In T 0670/20, the ques­tion was wheth­er the in­tern­al struc­ture of medi­cin­al tab­lets had been made avail­able to the pub­lic by pa­tients tak­ing part in clin­ic­al tri­als in­volving ad­min­is­tra­tion of the tab­lets...